Compare CWCO & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CWCO | CATX |
|---|---|---|
| Founded | 1973 | 1983 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 581.2M | 497.9M |
| IPO Year | 1997 | 2018 |
| Metric | CWCO | CATX |
|---|---|---|
| Price | $33.78 | $4.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $40.00 | $12.11 |
| AVG Volume (30 Days) | 111.6K | ★ 1.1M |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $132,073,368.00 | N/A |
| Revenue This Year | $4.34 | N/A |
| Revenue Next Year | $42.86 | N/A |
| P/E Ratio | $29.61 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $22.69 | $1.96 |
| 52 Week High | $39.12 | $6.16 |
| Indicator | CWCO | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 45.85 |
| Support Level | $32.78 | $3.93 |
| Resistance Level | $34.39 | $4.63 |
| Average True Range (ATR) | 0.99 | 0.31 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 45.59 | 33.54 |
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.